Israel Englander Insulet Corp Call Options Transaction History

Millennium Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$161.02 - $206.98 $3.22 Million - $4.14 Million	-20,000 Reduced 46.51%	23,000 $4.64 Million
Q1 2024 May 15, 2024	BUY	$163.6 - $209.11 $5.89 Million - $7.53 Million	36,000 Added 514.29%	43,000 $7.37 Million
Q4 2023 Feb 14, 2024	SELL	$127.77 - $221.42 $383,310 - $664,260	-3,000 Reduced 30.0%	7,000 $1.52 Million
Q2 2023 Aug 14, 2023	BUY	$272.48 - $330.23 $2.72 Million - $3.3 Million	10,000 New	10,000 $2.88 Million
Q4 2022 Feb 14, 2023	BUY	$212.22 - $313.46 $1.06 Million - $1.57 Million	5,000 Added 250.0%	7,000 $2.06 Million
Q3 2022 Nov 14, 2022	BUY	$224.6 - $281.45 $224,600 - $281,450	1,000 Added 100.0%	2,000 $459,000

659

63.5M

385K

773K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $16.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.